MMWR. Morbidity and mortality weekly report最新文献_第6页

Notes from the Field: Prevalence of Previous Dengue Virus Infection Among Children and Adolescents Aged 7-16 Years - American Samoa, September-October 2023. 现场笔记：7-16 岁儿童和青少年登革热病毒感染流行率 - 美属萨摩亚，2023 年 9-10 月。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-08-08 DOI: 10.15585/mmwr.mm7331a3

Sandra Kiplagat, Noelle Tavale, Adam Konrote, Astrid M Johansson, Angelynn Papu, Janice Perez-Padilla, Forrest K Jones, Hans Desale, Annette F Ilimaleota, Jacki M Tulafono, Mark Delorey, Emma Jones, Emi Chutaro, Janet Camacho, Freddy Medina, Rafael Tosado-Acevedo, Jorge L Munoz-Jordan, Gabriela Paz-Bailey, Laura E Adams, Motusa Tuileama Nua, Joshua M Wong, Scott Anesi

引用次数: 0

Erratum: Vol. 72, No. RR-6. 勘误：第 72 卷，第 RR-6 号。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-08-08 DOI: 10.15585/mmwr.mm7331a4

引用次数: 0

Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023. 儿童疫苗计划时代儿童常规免疫接种的健康和经济效益 - 美国，1994-2023 年。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-08-08 DOI: 10.15585/mmwr.mm7331a2

Fangjun Zhou, Tara C Jatlaoui, Andrew J Leidner, Rosalind J Carter, Xiaoyu Dong, Jeanne M Santoli, Shannon Stokley, Demetre C Daskalakis, Georgina Peacock

{"title":"Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023.","authors":"Fangjun Zhou, Tara C Jatlaoui, Andrew J Leidner, Rosalind J Carter, Xiaoyu Dong, Jeanne M Santoli, Shannon Stokley, Demetre C Daskalakis, Georgina Peacock","doi":"10.15585/mmwr.mm7331a2","DOIUrl":"10.15585/mmwr.mm7331a2","url":null,"abstract":"Since 1994, the U.S. Vaccines for Children (VFC) program has covered the cost of vaccines for children whose families might not otherwise be able to afford vaccines. This report assessed and quantified the health benefits and economic impact of routine U.S. childhood immunizations among both VFC-eligible and non-VFC-eligible children born during 1994-2023. Diphtheria and tetanus toxoids and acellular pertussis vaccine; Haemophilus influenzae type b conjugate vaccine; oral and inactivated poliovirus vaccines; measles, mumps, and rubella vaccine; hepatitis B vaccine; varicella vaccine; pneumococcal conjugate vaccine; hepatitis A vaccine; and rotavirus vaccine were included. Averted illnesses and deaths and associated costs over the lifetimes of 30 annual cohorts of children born during 1994-2023 were estimated using established economic models. Net savings were calculated from the payer and societal perspectives. Among approximately 117 million children born during 1994-2023, routine childhood vaccinations will have prevented approximately 508 million lifetime cases of illness, 32 million hospitalizations, and 1,129,000 deaths, at a net savings of $540 billion in direct costs and $2.7 trillion in societal costs. From both payer and societal perspectives, routine childhood vaccinations among children born during 1994-2023 resulted in substantial cost savings. Childhood immunizations continue to provide substantial health and economic benefits, while promoting health equity.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 31","pages":"682-685"},"PeriodicalIF":25.4,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309373/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Notes from the Field: Detection of Medetomidine Among Patients Evaluated in Emergency Departments for Suspected Opioid Overdoses - Missouri, Colorado, and Pennsylvania, September 2020-December 2023. 现场笔记：2020 年 9 月至 2023 年 12 月，在急诊科评估的疑似阿片类药物过量患者中检测到美托咪定 - 密苏里州、科罗拉多州和宾夕法尼亚州。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-08-01 DOI: 10.15585/mmwr.mm7330a3

Evan S Schwarz, Jennie Buchanan, Kim Aldy, Joshua Shulman, Alex Krotulski, Sara Walton, Barry Logan, Paul Wax, Sharan Campleman, Jeffrey Brent, Rachel Culbreth, Alex F Manini

引用次数: 0

QuickStats: Percentage* of Adult Day Services Centers^† That Use Any Telehealth,^§ by U.S. Census Bureau Region - United States, 2022^¶. QuickStats：按美国人口普查局地区分列的使用任何远程医疗的成人日间服务中心†的百分比*§ - 美国，2022¶。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-08-01 DOI: 10.15585/mmwr.mm7330a4

引用次数: 0

Lead Poisoning in a Mother and Her Four Children Using a Traditional Eye Cosmetic - New York City, 2012-2023. 使用传统眼部化妆品的母亲及其四个孩子的铅中毒情况 - 纽约市，2012-2023 年。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-08-01 DOI: 10.15585/mmwr.mm7330a2

Paromita Hore, Slavenka Sedlar, Jacqueline Ehrlich

{"title":"Lead Poisoning in a Mother and Her Four Children Using a Traditional Eye Cosmetic - New York City, 2012-2023.","authors":"Paromita Hore, Slavenka Sedlar, Jacqueline Ehrlich","doi":"10.15585/mmwr.mm7330a2","DOIUrl":"10.15585/mmwr.mm7330a2","url":null,"abstract":"Even low levels of lead in children's blood are associated with developmental delays, difficulty learning, and behavioral issues. Adults are also vulnerable to the detrimental health effects of lead exposure. The New York City (NYC) Department of Health and Mental Hygiene receives blood lead test results for NYC residents and conducts investigations of lead poisoning cases. Blood lead testing of a child aged 4 years in 2012 led to the discovery of blood lead levels above the CDC blood lead reference value of 3.5 μg/dL in the child as well as four other family members over a period of 11 years, including the child's mother and three younger siblings born during 2012-2016. The only potential source of lead exposure identified for all cases was the use of surma, a traditional eye cosmetic, which was found to contain 390,000 ppm lead. The cases in this report highlight the challenges of risk communication when deeply ingrained cultural practices, such as the use of surma, persist despite health warnings. Moreover, they highlight the intergenerational nature of such practices and the need for comprehensive family follow-up once a member is identified as being at risk. These products continue to be available globally, even in places such as the United States where sales are prohibited. Multistakeholder efforts involving local and global engagement could promote reformulation of these products at the countries of origin to eliminate lead as an ingredient.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 30","pages":"667-671"},"PeriodicalIF":25.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11305410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024. 2015 年 4 月至 2024 年 4 月格鲁吉亚消除乙型肝炎和丙型肝炎的进展情况。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-08-01 DOI: 10.15585/mmwr.mm7330a1

Rania A Tohme, Shaun Shadaker, Ekaterine Adamia, Irma Khonelidze, Ketevan Stvilia, Vladimer Getia, Maia Tsereteli, Maia Alkhazashvili, Akaki Abutidze, Maia Butsashvili, Maka Gogia, Nancy Glass, Sophia Surguladze, Irina Tskhomelidze Schumacher, Tamar Gabunia

{"title":"Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024.","authors":"Rania A Tohme, Shaun Shadaker, Ekaterine Adamia, Irma Khonelidze, Ketevan Stvilia, Vladimer Getia, Maia Tsereteli, Maia Alkhazashvili, Akaki Abutidze, Maia Butsashvili, Maka Gogia, Nancy Glass, Sophia Surguladze, Irina Tskhomelidze Schumacher, Tamar Gabunia","doi":"10.15585/mmwr.mm7330a1","DOIUrl":"10.15585/mmwr.mm7330a1","url":null,"abstract":"Hepatitis B and hepatitis C are leading causes of cirrhosis and liver cancer and caused 1.3 million deaths worldwide in 2022. Hepatitis B is preventable with vaccination, and hepatitis C is curable with direct-acting antivirals. In 2015, in collaboration with CDC and other partners, Georgia, a country at the intersection of Europe and Asia, launched a hepatitis C elimination program to reduce the prevalence of chronic hepatitis C; at that time, the prevalence was 5.4%, more than five times the global average of 1.0%. In 2016, the World Health Assembly endorsed a goal for the elimination of viral hepatitis as a public health problem by 2030. In 2024, 89% of the Georgian adult population have received screening for hepatitis C, 83% of persons with current chronic HCV infection have received a diagnosis, and 86% of those with diagnosed hepatitis C have started treatment. During 2015-2023, vaccination coverage with the hepatitis B birth dose and with 3 doses of hepatitis B vaccine among infants exceeded 90% for most years. In 2021, the prevalence of hepatitis B surface antigen was 0.03% among children and adolescents aged 5-17 years and 2.7% among adults. Georgia has demonstrated substantial progress toward hepatitis B and hepatitis C elimination. Using lessons from the hepatitis C elimination program, scale-up of screening and treatment for hepatitis B among adults would prevent further viral hepatitis-associated morbidity and mortality in Georgia and would accelerate progress toward hepatitis B and hepatitis C elimination by 2030.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 30","pages":"660-666"},"PeriodicalIF":25.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11305411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Suspected Counterfeit M-30 Oxycodone Pill Exposures and Acute Withdrawals Reported from a Single Hospital - Toxicology Investigators Consortium Core Registry, U.S. Census Bureau Western Region, 2017-2022. 单家医院报告的疑似假冒 M-30 氧可酮药片暴露和急性戒断 - 毒理学调查员联盟核心登记处，美国人口普查局西部地区，2017-2022 年。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-25 DOI: 10.15585/mmwr.mm7329a2

Emily Glidden, R Matthew Gladden, Chris Dion, Meghan B Spyres, Puja Seth, Kim Aldy, Desiree Mustaquim

{"title":"Suspected Counterfeit M-30 Oxycodone Pill Exposures and Acute Withdrawals Reported from a Single Hospital - Toxicology Investigators Consortium Core Registry, U.S. Census Bureau Western Region, 2017-2022.","authors":"Emily Glidden, R Matthew Gladden, Chris Dion, Meghan B Spyres, Puja Seth, Kim Aldy, Desiree Mustaquim","doi":"10.15585/mmwr.mm7329a2","DOIUrl":"10.15585/mmwr.mm7329a2","url":null,"abstract":"Availability of counterfeit prescription pills (counterfeit pills) containing illegally made fentanyl, including counterfeit M-30 oxycodone (counterfeit M-30) pills, has risen sharply in the United States and has been increasingly linked to overdose deaths. In 2023, approximately 115 million counterfeit pills were seized in U.S. High Intensity Drug Trafficking Areas. However, clinical data on counterfeit pill-related overdoses are limited. Medical toxicology consultations during 2017-2022 from one U.S. Census Bureau Western Region hospital participating in the Toxicology Investigators Consortium Core Registry were analyzed. A total of 352 cases suspected to involve counterfeit M-30 pills, including 143 (40.6%) cases of fentanyl exposure and 209 (59.4%) cases of acute withdrawal were identified; consultations increased from three in 2017, to 209 in 2022. Patients aged 15-34 years accounted for 95 (67.4%) exposure cases. Among all patients with exposures, 81.1% were hospitalized, 69.0% of whom were admitted to an intensive care unit. Additional substances were detected in 131 (91.6%) exposures. Providing outreach to younger persons misusing prescription pills, improving access to and distribution of harm reduction tools including fentanyl test strips and naloxone, and promoting linkage of persons treated for overdose in hospitals to harm reduction and substance use treatment services are strategies to reduce morbidity associated with use of counterfeit M-30.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 29","pages":"642-647"},"PeriodicalIF":25.4,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11290911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Notes from the Field: Health Monitoring, Testing, and Case Identification Among Persons Exposed to Influenza A(H5N1) - Michigan, 2024. 现场笔记：暴露于甲型 H5N1 流感者的健康监测、检测和病例鉴定 - 密歇根州，2024 年。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-25 DOI: 10.15585/mmwr.mm7329a4

Joseph Coyle, Natasha Bagdasarian, Seth Eckel, Jeremy Kuo, Mary Grace Stobierski, James Barber, Megan Weinberg, Fatema Mamou, Sarah Lyon-Callo

引用次数: 0

Adult Smoking Cessation - United States, 2022. 成人戒烟率 - 美国，2022 年。

IF 25.4 1区医学

MMWR. Morbidity and mortality weekly report Pub Date : 2024-07-25 DOI: 10.15585/mmwr.mm7329a1

Brenna VanFrank, Ann Malarcher, Monica E Cornelius, Anna Schecter, Ahmed Jamal, Michael Tynan

{"title":"Adult Smoking Cessation - United States, 2022.","authors":"Brenna VanFrank, Ann Malarcher, Monica E Cornelius, Anna Schecter, Ahmed Jamal, Michael Tynan","doi":"10.15585/mmwr.mm7329a1","DOIUrl":"10.15585/mmwr.mm7329a1","url":null,"abstract":"Tobacco dependence is a chronic condition driven by nicotine addiction. Successful quitting can be increased by health care provider intervention and evidence-based treatment. CDC assessed national estimates of cigarette smoking cessation indicators among U.S. adults using 2022 National Health Interview Survey data. In 2022, approximately two thirds (67.7%) of the 28.8 million U.S. adults who smoked wanted to quit, and approximately one half (53.3%) made a quit attempt, but only 8.8% quit smoking. One half of adults who smoked and saw a health professional during the past year received health professional advice (50.5%) or assistance (49.2%) to quit smoking. Among those who tried to quit, 38.3% used treatment (i.e., counseling or medication). Adults who usually smoked menthol (versus nonmenthol) cigarettes had higher prevalences of quitting interest (72.2% versus 65.4%; p<0.05) and past-year quit attempts (57.3% versus 50.4%; p<0.05), lower prevalences of receiving quit advice (48.2% versus 53.8%; p<0.05) and using cessation treatment (35.2% versus 41.5%; p<0.05), but similar prevalence of quit success (9.5% versus 7.9%; p = 0.19). Opportunities exist for both public health and health care sectors to increase smoking cessation, including expanding access to and utilization of cessation services and supports. Incorporating equitable cessation strategies into all commercial tobacco prevention and control efforts can help advance and support smoking cessation for all population groups.","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 29","pages":"633-641"},"PeriodicalIF":25.4,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11290909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141759712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0